Multiple Sclerosis Trial, By Invitation NCT07011875 Sponsor: Karabuk University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, By Invitation

NCT07011875
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women who have been diagnosed with multiple sclerosis by a neurologist
  • People aged between 18 and 55 years
  • People who currently have an active menstrual cycle
  • People whose menstrual cycle is regular, meaning it occurs every 24 to 35 days
  • People who do not have any physical or thinking/memory difficulties that would prevent them from taking part in exercise
  • People who are willing to take part in the study

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have gone through menopause
  • People who are currently pregnant or breastfeeding
  • People who use hormonal contraceptives (such as the pill or hormonal implants) or have an intrauterine device (IUD)
  • People who take any medication that may affect period pain
  • People who have had any gynaecological surgery in the past
  • People who have a pelvic condition such as pelvic inflammatory disease, endometriosis, or any other condition known to cause period pain

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Karabuk University
Registry
ClinicalTrials.gov
Start date
2 June 2025
Est. completion
1 August 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Numerical Rating Scale; Functional and Emotional Impact of Dysmenorrhea; International Physical Activity Questionnaire - Short Form; Patient Determined Disease Steps; Menstrual Symptom Questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov